“We are counting on the end of the acute phase of the pandemic this year, provided that 70 percent of the world’s population is vaccinated by the middle of the year, around June or July,” Ghebreyesus said during a visit to a vaccine factory in South Africa.
“It’s in our hands. It’s a matter of choice,” Ghebreyesus was quoted by AFP as saying.
Ghebreyesus was visiting the laboratories of the “Afrigen” company in Cape Town, which manufactured the first anti-Covid 19 vaccine in Africa, to be ready for clinical trials in November, and it is expected to start work in 2024.
And the director of the World Health Organization said that “this vaccine will be more adapted to the conditions in which it is used, with fewer storage restrictions and a lower price.”
The Africa project is supported by the World Health Organization and the Kovacs International Platform to facilitate access to vaccines.
The proportion of those who received the vaccine in Africa does not exceed 11 percent, which is the lowest in the world.
And the branch of the World Health Organization on the continent considered that it should “double 6 times the vaccination rate” against Corona, hoping to reach the desired 70 percent by the end of the first half of 2022.